EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER

Our surveillance was performed for 358 patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH. Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 136) received treatment with 75 mg Buserelin-depo 3....

Full description

Bibliographic Details
Main Authors: S. V. MISHUGIN, A. A. DROBYAZKO, A. A. MORDOVIN, A. A. GRICKEVICH, I. G. RUSAKOV
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-06-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1893